Option chain shows key data for Elevation Oncology's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Elevation Oncology.

Elevation Oncology (NASDAQ:ELEV) Stock, Option Chain

Elevation Oncology

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

Tesla, Inc. TSLA

News

Price Target

Markets

Analyst Ratings

CURV

ELEV

SMCI

TSLA

Tesla To $410? Here Are 10 Top Analyst Forecasts For Friday

Trade tensions weigh on oil demand

Earnings

Equities

Eurozone

Commodities

Intraday Update

Trading Ideas

AKBA

BHIL

OPTN

WINT

Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase

bz_pharma_briefs

Biotech

Health Care

Movers

General

Elevation Oncology ends EO-3021 development after Phase 1 results, shifts focus to EO-1022, and plans a major workforce reduction to extend funding.

Elevation Oncology Stops Gastric Cancer Study, Slashes Staff By 70%

Elevation Oncology Inc

Elevance Health Inc

ELEVATE URANIUM LTD by Elevate Uranium Ltd.

Elevate Uranium Ltd

Elevation Gold Mining Corp

ELEVATION GOLD MNG CORP by Elevation Gold Mining Corporation

Elevation Series Trust Clough Hedged Equity ETF

Elevation Series Trust Clough Select Equity ETF

Elevation Series Trust SRH REIT Covered Call ETF

Elevation Series Trust Sovereign's Capital Flourish Fund

Elevation Series Trust The Opal International Dividend Income ETF

Elevation Series Trust TrueShares Quarterly Bear Hedge ETF

Elevation Series Trust TrueShares Quarterly Bull Hedge ETF

Elevation Series Trust TrueShares Seasonality Laddered Buffered ETF

Press Releases

Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference

Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors

Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones

Small Cap

Opinion

Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year

Elevation Oncology to Participate in Upcoming Investor Conferences

Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options

Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

ADPT

LZAGY

ONCY

ORIC

TSX:ONC

Abpro Hldgs

ABVC BioPharma

BioAtla

BioVie

Cardio Diagnostics Holdings Inc. - Common stock

Cardio Diagnostics Hldgs

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics

Equillium

GlycoMimetics

Kala Bio

Kairos Pharma

Leap Therapeutics

Lisata Therapeutics

MEI Pharma

MetaVia

Mural Oncology

Nanoviricides

Ovid Therapeutics

BiomX

Polyrizon

Portage Biotech

Tenax Therapeutics

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

Unity Biotechnology

Stephens & Co.

Piper Sandler

Citizens Capital Markets

Leerink Partners

HC Wainwright & Co.

Comments

Elevation Oncology

Elevation Oncology (ELEV) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga